Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI)
US-RE47150-E · Dec 4, 2018 · US
Pan Junliang is listed as an inventor on 7 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Pan Junliang |
| Total patents | 7 |
| First publication | Apr 12, 2016 |
| Latest publication | Dec 4, 2018 |
Publications ranked by popularity score, then publication date.
US-RE47150-E · Dec 4, 2018 · US
US-2018334509-A1 · Nov 22, 2018 · US
US-10035840-B2 · Jul 31, 2018 · US
US-2017342162-A1 · Nov 30, 2017 · US
US-2017051042-A1 · Feb 23, 2017 · US
US-9422362-B2 · Aug 23, 2016 · US
US-9309324-B2 · Apr 12, 2016 · US
Latest publications not already listed above.
No data yet.
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Bayer Healthcare Llc | 7 |
| Wang Zhuozhi | 1 |
| Pan Junliang | 1 |
| Grudzinska Joanna | 1 |
| Votsmeier Christian | 1 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P7/04 | 7 |
| A61P43/00 | 4 |
| C07K16/38 | 4 |
| C07K2317/92 | 4 |
| A61K39/395 | 4 |